IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 39 filers reported holding IBERE PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,027,000 | +1.8% | 300,000 | 0.0% | 0.07% | +2.9% |
| Q3 2022 | $2,973,000 | +1.0% | 300,000 | 0.0% | 0.07% | -10.3% |
| Q2 2022 | $2,943,000 | 0.0% | 300,000 | 0.0% | 0.08% | +4.0% |
| Q1 2022 | $2,943,000 | +0.9% | 300,000 | 0.0% | 0.08% | +29.3% |
| Q4 2021 | $2,916,000 | +0.3% | 300,000 | 0.0% | 0.06% | +31.8% |
| Q3 2021 | $2,907,000 | +0.2% | 300,000 | 0.0% | 0.04% | +7.3% |
| Q2 2021 | $2,901,000 | – | 300,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |